GoodRx Expands Access to Ozempic

GoodRx shares soar after announcing the company’s partnership with Novo Nordisk to slash the cost of Ozempic. GoodRx CEO Wendy Barnes tells Open Interest that the platform allows patients to get the best drug prices at retail pharmacies. (Source: Bloomberg)

Redirecting to full article...